These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 1596288)
1. Binding of [3H]bryostatin 4 to protein kinase C. Lewin NE; Dell'Aquila ML; Pettit GR; Blumberg PM; Warren BS Biochem Pharmacol; 1992 May; 43(9):2007-14. PubMed ID: 1596288 [TBL] [Abstract][Full Text] [Related]
2. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes. Kazanietz MG; Lewin NE; Gao F; Pettit GR; Blumberg PM Mol Pharmacol; 1994 Aug; 46(2):374-9. PubMed ID: 8078499 [TBL] [Abstract][Full Text] [Related]
3. Demonstration of sub-nanomolar affinity of bryostatin 1 for the phorbol ester receptor in rat brain. de Vries DJ; Herald CL; Pettit GR; Blumberg PM Biochem Pharmacol; 1988 Nov; 37(21):4069-73. PubMed ID: 3190746 [TBL] [Abstract][Full Text] [Related]
4. Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and by bryostatin 1. Pasti G; Rivedal E; Yuspa SH; Herald CL; Pettit GR; Blumberg PM Cancer Res; 1988 Jan; 48(2):447-51. PubMed ID: 3422054 [TBL] [Abstract][Full Text] [Related]
5. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1. Basu A; Lazo JS Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725 [TBL] [Abstract][Full Text] [Related]
6. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity phorbol ester receptor. Analysis of ligand-binding interactions, lipid cofactor requirements, and inhibitor sensitivity. Kazanietz MG; Lewin NE; Bruns JD; Blumberg PM J Biol Chem; 1995 May; 270(18):10777-83. PubMed ID: 7537738 [TBL] [Abstract][Full Text] [Related]
8. Residues in the second cysteine-rich region of protein kinase C delta relevant to phorbol ester binding as revealed by site-directed mutagenesis. Kazanietz MG; Wang S; Milne GW; Lewin NE; Liu HL; Blumberg PM J Biol Chem; 1995 Sep; 270(37):21852-9. PubMed ID: 7665608 [TBL] [Abstract][Full Text] [Related]
10. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1. Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. Szallasi Z; Smith CB; Pettit GR; Blumberg PM J Biol Chem; 1994 Jan; 269(3):2118-24. PubMed ID: 8294465 [TBL] [Abstract][Full Text] [Related]
12. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D. Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664 [TBL] [Abstract][Full Text] [Related]
13. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070 [TBL] [Abstract][Full Text] [Related]
14. Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C. Wender PA; Cribbs CM; Koehler KF; Sharkey NA; Herald CL; Kamano Y; Pettit GR; Blumberg PM Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7197-201. PubMed ID: 3174627 [TBL] [Abstract][Full Text] [Related]
15. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells. Sako T; Yuspa SH; Herald CL; Pettit GR; Blumberg PM Cancer Res; 1987 Oct; 47(20):5445-50. PubMed ID: 2888531 [TBL] [Abstract][Full Text] [Related]
16. Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSF. McCrady CW; Staniswalis J; Pettit GR; Howe C; Grant S Br J Haematol; 1991 Jan; 77(1):5-15. PubMed ID: 1998597 [TBL] [Abstract][Full Text] [Related]
17. Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products. Kazanietz MG; Bustelo XR; Barbacid M; Kolch W; Mischak H; Wong G; Pettit GR; Bruns JD; Blumberg PM J Biol Chem; 1994 Apr; 269(15):11590-4. PubMed ID: 8157692 [TBL] [Abstract][Full Text] [Related]
18. Binding of [26-3H]-epi-bryostatin 4 to protein kinase C. Lewin NE; Pettit GR; Kamano Y; Blumberg PM Cancer Commun; 1991 Mar; 3(3):67-70. PubMed ID: 2001329 [TBL] [Abstract][Full Text] [Related]
19. Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells. Ramsdell JS; Pettit GR; Tashjian AH J Biol Chem; 1986 Dec; 261(36):17073-80. PubMed ID: 3465727 [TBL] [Abstract][Full Text] [Related]